Zinc Polyphosphate Nanoparticles for Intestinal Barrier Enhancement
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current anti-inflammatory drugs for inflammatory bowel disease (IBD) primarily focus on symptomatic treatment rather than mucosal healing, and the mechanism of probiotics' intestinal regulation effects is unclear, necessitating the development of a more effective pharmaceutical agent that enhances intestinal barrier function.
Innovation Solution
A novel zinc polyphosphate characterized by specific X-ray diffraction peaks, zeta potential, and chain length, produced under controlled alkaline conditions, exhibits high intestinal barrier enhancing activity and is formulated as nanoparticles.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional anti-inflammatory drugs are used for symptomatic treatment, then immediate symptom relief is achieved, but mucosal healing and long-term intestinal barrier function improvement are not achieved
Solution Approach 1:
The patent changes the chemical composition parameter by using zinc polyphosphate instead of conventional anti-inflammatory drugs, and controls the degree of polymerization (1-100 phosphate units) to achieve both symptomatic relief and mucosal healing effects simultaneously
Solution Approach 2:
The patent creates a composite material system consisting of zinc polyphosphate with specific chain lengths, formulated as nanoparticles with controlled size distribution, combining the benefits of zinc ions and polyphosphate chains for enhanced intestinal barrier function
2Reliability
If probiotics are used for intestinal regulation, then safety and certain regulatory effects are achieved, but the mechanism of action remains unclear and efficacy is limited
Solution Approach 1:
The patent extracts and isolates the active polyphosphate component from probiotics, formulating it as pure zinc polyphosphate nanoparticles with defined molecular characteristics, thereby clarifying the mechanism while maintaining the beneficial effects
Solution Approach 2:
The patent uses zinc polyphosphate as an intermediary substance that mediates between the probiotic effect and the intestinal barrier, providing a clear mechanism of action through its specific interaction with intestinal epithelial cells and tight junction proteins
3Adaptability or versatility
If polyphosphate with different chain lengths is used, then various biological effects are achieved, but controlling the degree of polymerization and maintaining stability is difficult
Solution Approach 1:
The patent precisely controls the degree of polymerization parameter within the range of 1-100 phosphate units, with preferred ranges of 2-50 and more preferably 5-20 units, to optimize both biological activity and manufacturing feasibility
Solution Approach 2:
The patent applies different polyphosphate chain lengths for different applications: shorter chains (2-10 units) for stability and longer chains (10-100 units) for enhanced biological activity, allowing optimization based on specific therapeutic needs
4Reliability
If zinc polyphosphate is formulated as nanoparticles, then intestinal barrier enhancing activity is improved, but production complexity and purification difficulty increase
Solution Approach 1:
The patent utilizes the self-assembly property of zinc polyphosphate under controlled pH conditions (pH 8-10) to spontaneously form nanoparticles with desired size distribution, eliminating the need for complex nanoparticle fabrication equipment and processes
Solution Approach 2:
The patent controls the pH parameter during preparation to induce nanoparticle formation, and adjusts zinc ion concentration and polyphosphate chain length to achieve optimal particle size and stability without requiring sophisticated processing equipment
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The zinc polyphosphate demonstrates excellent intestinal barrier enhancement, maintaining activity for extended periods and effectively treating injured gastrointestinal mucosa, inducing and maintaining remission of IBD, while inhibiting inflammatory cytokines.
Implementation Method 1
showing a halo peak at 2θ = 4 to 7° in X-ray diffraction
Data Source
Figure 1A
Figure 1B
Figure 1C
AI summary
The present invention relates to a novel zinc polyphosphate, use thereof, and a production method therefor. The present invention relates more specifically to a zinc polyphosphate characterized by showing a halo peak at 2θ = 4 to 7° in X-ray diffraction, a pharmaceutical composition containing the zinc polyphosphate as an active ingredient, and a method for producing a zinc polyphosphate, the method comprising the steps of: (1) adding a zinc ion to a polyphosphate solution under an alkaline condition at preferably pH 8 to 11; and (2) recovering a solid obtained in the step (1) as a zinc polyphosphate.